BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19655639)

  • 21. UNHCR: new strategy for provision of antiretroviral therapy to refugees.
    Robinson C
    HIV AIDS Policy Law Rev; 2007 May; 12(1):36, 38. PubMed ID: 17715535
    [No Abstract]   [Full Text] [Related]  

  • 22. Differentiated Antiretroviral Therapy Delivery: Implementation Barriers and Enablers in South Africa.
    Sharer M; Davis N; Makina N; Duffy M; Eagan S
    J Assoc Nurses AIDS Care; 2019; 30(5):511-520. PubMed ID: 30720561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 24. Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania.
    Wringe A; Roura M; Urassa M; Busza J; Athanas V; Zaba B
    AIDS Care; 2009 May; 21(5):632-7. PubMed ID: 19444672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of ART scale upon health workers: evidence from two South African districts.
    George G; Atujuna M; Gentile J; Quinlan T; Schmidt E; Tobi P; Renton A
    AIDS Care; 2010; 22 Suppl 1():77-84. PubMed ID: 20229372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of antiretroviral therapy coverage: methodology and trends.
    Mahy M; Tassie JM; Ghys PD; Stover J; Beusenberg M; Akwara P; Souteyrand Y
    Curr Opin HIV AIDS; 2010 Jan; 5(1):97-102. PubMed ID: 20046154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capacity of health-care facilities to deliver HIV treatment and care services, Northern Tanzania, 2004.
    Landman KZ; Kinabo GD; Schimana W; Dolmans WM; Swai ME; Shao JF; Crump JA
    Int J STD AIDS; 2006 Jul; 17(7):459-62. PubMed ID: 16820075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
    Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    World Hosp Health Serv; 2008; 44(1):26-9. PubMed ID: 18549031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond the numbers: using rights-based perspectives to enhance antiretroviral treatment scale-up.
    Gruskin S; Ferguson L; Bogecho DO
    AIDS; 2007 Oct; 21 Suppl 5():S13-9. PubMed ID: 18090263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refugee participation in health relief services during the post-emergency phase in Tanzania.
    Tanaka Y; Kunii O; Okumura J; Wakai S
    Public Health; 2004 Jan; 118(1):50-61. PubMed ID: 14643627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "We are just supposed to be quiet": the production of adherence to antiretroviral treatment in urban Tanzania.
    Mattes D
    Med Anthropol; 2011 Mar; 30(2):158-82. PubMed ID: 21400351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda.
    Muhamadi L; Nsabagasani X; Tumwesigye MN; Wabwire-Mangen F; Ekström AM; Peterson S; Pariyo G
    Health Policy; 2010 Oct; 97(2-3):187-94. PubMed ID: 20615573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The introduction of antiretroviral therapy in Malawi].
    Zijlstra EE; van Oosterhout JJ
    Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2774-8. PubMed ID: 17225792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocity and post-trial access for participants in antiretroviral therapy trials.
    Merritt M; Grady C
    AIDS; 2006 Sep; 20(14):1791-4. PubMed ID: 16954719
    [No Abstract]   [Full Text] [Related]  

  • 37. Scale-up of national antiretroviral therapy programs: progress and challenges in the Asia Pacific region.
    Srikantiah P; Ghidinelli M; Bachani D; Chasombat S; Daoni E; Mustikawati DE; Nhan do T; Pathak LR; San KO; Vun MC; Zhang F; Lo YR; Narain JP
    AIDS; 2010 Sep; 24 Suppl 3():S62-71. PubMed ID: 20926930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
    Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    J Infect Dev Ctries; 2007 Dec; 1(3):303-7. PubMed ID: 19734609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migrants' access to antiretroviral therapy in Thailand.
    Saether ST; Chawphrae U; Zaw MM; Keizer C; Wolffers I
    Trop Med Int Health; 2007 Aug; 12(8):999-1008. PubMed ID: 17697095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV testing strategies across European countries.
    Mounier-Jack S; Nielsen S; Coker RJ
    HIV Med; 2008 Jul; 9 Suppl 2():13-9. PubMed ID: 18557864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.